Multilingual Content Under MDR – When Language Becomes Regulatory Evidence – Despoina Polyzoidou

Navigating Regional Language Requirements Across Markets

The White Paper maps how language obligations differ by jurisdiction, with MDR as the strictest common denominator for global manufacturers. It covers the EU’s requirement that information supplied with a device be available in each Member State’s official language(s), linked implicitly to the General Safety and Performance Requirements in Annex I. It also examines the US model, where the FDA imposes no multilingual obligation but manufacturers remain fully accountable for accuracy in any language provided and other markets such as Canada, Japan and China, where language requirements are tied directly to market authorisation.

Identifying When Multilingual Content Enters the QMS

The White Paper clarifies a question that frequently causes uncertainty for RA and QA teams: When does a translation stop being a linguistic output and become a controlled document? It explains that the trigger is not wordcount, device class, or market size, but intended use and regulatory reliance. This includes conformity assessment, market placement, safe and effective use,and audit or submission evidence. It also outlines the common gap that arises when translations are operationally complete but not yet formally integrated into document control systems.

Qualifying Suppliers as a Controlled External Process

The White Paper sets out what regulatory-grade supplier qualification actually requires, beyond language proficiency. It details the criteria RA and QA teams should apply when selecting a language service provider, including certified competence in medical devices and regulated content, structured workflows aligned with regulatory language requirements, secure handling of sensitive documentation, professional liability coverage and the ability to produce objective evidence such as translation certification, blind linguist CVs and audit trails.

Structuring Translation as a Regulated, Auditable Process

The White Paper walks through what a compliant translation workflow looks like under the combined lens of ISO 17100, ISO 13485 and MDR. It covers translation and independent revision by qualified, subject-matter-native linguists, structured linguistic and technical QA, controlled terminology resources, documented traceability and version history and MDR-compliant formatting. It also addresses linguistic drift as an often-overlooked risk and explains how treating language as a change-managed asset with translation impact assessments, curated translation memories and periodic legacy review, keeps multilingual content audit-ready over time.